Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy

NCT07713537 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-07-20

No results posted yet for this study

Summary

Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). Evidence-based scale is necessary to assess ischemic stroke risk in atrial fibrillation (AF) patients.

Conditions

Interventions

OTHER

DOAC Level

Testing for plasma DOAC level concentration to determine 'on-therapy' status

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07713537 on ClinicalTrials.gov